A Phase 2a clinical trial of LM11A-31 in early Alzheimer’s disease

Cited in blog · Journal of Experimental Medicine. · 2024

Longo, F. M., et al. (2024). A Phase 2a clinical trial of LM11A-31 in early Alzheimer’s disease. Journal of Experimental Medicine.